FDA BPA decision is a step forward, but more needs to happen, says MU expert

Jan 19, 2010

The FDA shifted its stance on bisphenol A (BPA) and said that exposure to the chemical is of "some concern" for infants and children. Previously, the agency's stance was the chemical posed no risk to humans; this stance was consistent with the chemical industry's stance. Today, FDA officials declared that more research was needed and suggested reasonable steps to reduce exposure to BPA.

Frederick vom Saal, a University of Missouri scientist, says that this stance is a step forward but more steps need to be taken. Since 1997, research from vom Saal and other MU colleagues have shown adverse health effects of BPA at exposure levels below those currently considered safe by the FDA. Vom Saal has received more than $1 million of the $30 million that government agencies, including the NIH, have committed in the next 18 to 25 months to study the of BPA exposure.

"The FDA formally acknowledging concern about BPA and working with NIH to incorporate research from outside of the chemical industry is a huge step forward," said vom Saal, who is a Curator's professor of biological sciences in MU's College of Arts and Science. "The FDA position presented today is consistent with the position that the National Toxicology Program made two years ago. Since then, considerable published research reaffirmed the health dangers of BPA. The FDA says they want to respond more quickly. Now, we will see if they are really able to respond to the huge amount of new science showing dangers not recognized two years ago. They should move quickly to restrict the use of by BPA in products used by adults as well as infants."

BPA is a one of the world's highest production-volume chemicals and has been used for 40 years to make hard plastic items, such as, drinking glasses, , food-storage containers, the lining of food and beverage containers, and dental sealants. Previous studies have shown of BPA on the brain and , as well as metabolic diseases in laboratory animals.

"The Japanese industry voluntarily removed BPA from can linings 10 years ago and thus, were able to reduce exposure to BPA by 50 percent," vom Saal said. "Last year, Congress asked companies in the United States to take similar actions; however, companies have made no move toward compliance. A huge problem facing the FDA is that it does not have the regulatory authority to even determine what products contain BPA, and Congress will have to pass new laws giving the FDA the authority it needs to regulate chemicals such as ."

Explore further: Testosterone testing has increased in recent years

add to favorites email to friend print save as pdf

Related Stories

FDA: BPA affects children; exposure should be limited

Jan 17, 2010

After earlier statements that declared bisphenol A safe for all uses, the U.S. Food and Drug Administration said Friday that BPA affects human development and said it is working to take the chemical out of infant formula ...

Study: BPA research might have been bias

Apr 17, 2007

A U.S. scientific journal says bias might have resulted in inconsistent study results concerning the danger of a chemical found in many products.

Recommended for you

Testosterone testing has increased in recent years

Nov 21, 2014

(HealthDay)—There has been a recent increase in the rate of testosterone testing, with more testing seen in men with comorbidities associated with hypogonadism, according to research published online Nov. ...

AMA: Hospital staff should consider impact of CMS rule

Nov 21, 2014

(HealthDay)—Hospital medical staff members need to consider the impact of a final rule issued by the Centers for Medicare & Medicaid Services (CMS) that revised the conditions of participation for hospitals ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.